In recent years, the pharmaceutical industry has been confronted with rising R&D costs paired with decreasing productivity. Attrition rates for new molecules are tremendous, with a substantial number of molecules failing in an advanced stage of development. Repositioning previously approved drugs for new indications can mitigate these issues by reducing both risk and cost of development. Computational methods have been developed to allow for the prediction of drug-target interactions, but it remains difficult to branch out into new areas of application where information is scarce.
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Here, we present a proof-of-concept for discovering patterns in protein-ligand data using frequent itemset mining. Two key advantages of our method are the transferability of our patterns to different application domains and the facile interpretation of our recommendations. Starting from a set of known protein-ligand relationships, we identify patterns of molecular substructures and protein domains that lie at the basis of these interactions. We show that these same patterns also underpin metabolic pathways in humans. We further demonstrate how association rules mined from human protein-ligand interaction patterns can be used to predict antibiotics susceptible to bacterial resistance mechanisms.
INTRODUCTION

34
The pharmaceutical industry has been confronted with a decline in R&D productivity. Indeed, the 35 industry has been said to face a productivity crisis. [1] The drug development process is an expensive 36 and time-consuming endeavor, with estimated costs for new drugs reaching up to 2.6 billion USD and 37 a time-to-approval ranging from 10 to 17 years. [ identify a rule, for instance when a customer purchases milk and bread, he will also purchase butter.
78
These rules could then be used to guide marketing decision making.
79
In recent years, frequent itemset mining has also been applied to a number of problems in but this comes at the expense of interpretability. These approaches tend to be black boxes, where 86 it is difficult to gain insight into the inner workings of the predictions. In contrast, as frequent 87 itemset mining produces an explicit list of patterns and recommendation rules, the interpretation is 88 straightforward. Furthermore, frequent itemset mining may be used as part of a pipeline to select 89 features for use in more advanced machine learning models.
90
Starting from known protein-ligand relationships, we uncover patterns consisting of molecular 91 substructures and protein domains that underlie these relationships. We demonstrate how these 92 2/13 patterns can be used to explain metabolic pathway data and we further show how this approach can 93 be used to predict antibiotic resistance.
94
MATERIALS AND METHODS
95
Problem description
96
Our goal is to obtain a set of patterns from the transactional dataset containing molecular fingerprint 97 keys for the ligands and domains for the proteins. To this end, we will use frequent itemset mining 98 to discover which chemical structure elements and domains frequently co-occur. The method is 99 illustrated in figure 1.
100
Frequent itemset mining
101
Frequent itemset mining discovers frequently co-occurring items in a transactional data set. In and head, i.e. x ∪ y. Given that many rules are produced in this step and the most frequent rules are 115 not necessarily the most interesting ones, we can further prune them using additional interestingness 116 measures, confidence and lift. The confidence in a given rule is the frequency with which the rule was 117 found to be correct. The lift for a given rule is defined as the frequencies for both items occurring 118 together divided by the frequency by which either item occurs.
119
To mine the association rules we used the R package arules [ Starting from protein-ligand data, a transactional dataset was created consisting of fingerprint keys of the ligands and the domains of the proteins. We mined for frequent itemsets, retaining only those itemsets with at least one molecular fingerprint key and one domain. These frequent patterns were then minded for association rules of the form: protein domain d is associated with molecular fingerprint key f p.
4/13
reduces the dimensionality of our mining, and its availability across many different cheminformatics 
f60 [S=O], f33 [NS], IPR000863 [Sulfotransferase domain]
169
These patterns provide insight into which items frequently co-occur. In section 3.2 we compare the 170 patterns mined from the STITCH database to the patterns governing the interactions in an independent 171 metabolite-protein dataset.
172
After obtaining frequent patterns, we mined them for association rules. We retain only those 173 rules that contain one or more protein domain(s) in the body and a molecular fingerprint in the 174 head. This step filters uninteresting itemsets that do not contain a combination of both domain and 175 structural information. Due to the restriction to the size of the itemset to three, we only consider rules 176 that contain either one or two protein domains in its body and one molecular fingerprint key in its head. The following example shows a rule stating that proteins with a sulfotransferase domain will 178 frequently interact with an SO 3 substructure. 
IPR000863 [Sulfotransferase domain] ⇒ f39 [SO 3 ]
181
In order to select interesting rules, we will further filter them based on two metrics describing 182 the performance of the rule in its original dataset -confidence and lift. Rules which meet the given 183 criteria will be used to predict the interactions between antibiotics and antibiotic resistance proteins 
Similar molecular patterns describe metabolic pathways
192
Having identified a set of patterns in a ligand-protein dataset, we then sought to investigate whether 193 similar patterns also describe metabolic pathways in humans. Starting from the pathway-metabolite 194 data (3,527 pathways in total), we mined all present metabolite structural fingerprint-domain patterns.
195
We then compared the patterns we mined from the protein-ligand dataset to the patterns mined 196 from the metabolite dataset. Fischer's exact test was then used to determine whether the patterns 197 derived from the STITCH database correlate well with the patterns derived from ConsensusPathDB.
198
A contingency table for our patterns is given in resistance, we used our set of association rules in the following fashion: for every protein from 224 CARD, represented by protein domains, we identified the set of rules containing those protein 225 domains in the rule body. These rules were then used to recommend substructures for the protein,
226
sorted by the mean confidence of the rule recommending them. In order to determine whether these 227 recommended substructures are statistically superior to randomly assigning substructures to protein 228 domains, we used a Fisher's exact test in the same manner as previously described, here comparing 229 our recommended patterns to the patterns mined from the resistance protein -antibiotic transactions.
230 Figure 5 shows the p-values for this test, which indicates that our method is able to provide relevant 231 recommendations.
232
We furthermore calculate a receiver operator characteristic (ROC) curve for these recommenda- The fingerprint recommendations we have generated for each antibiotic resistance protein were 240 then used to rank all 151 antibiotics by the likelihood of being affected by this resistance mechanism.
241
The results are summed up in Table 2 . While the mean rank of the true hit was low (68), at least one 242 correct antibiotic was ranked within the top fifteen for 28% of the proteins. 
CONCLUSION
244
The prediction of interactions between drugs and their targets is central to the field of cheminformatics. 
261
The itemset mining approach we use here is conceptually elegant and provides easy to understand 262 recommendations. Another key advantage is that it is highly flexible, allowing for the inclusion of a 263 variety of discrete features. In future work, the itemsets examined here may be extended to include 264 additional features of the protein such as post-translational modifications or amino acid mutations.
265
More elaborate substructure key based fingerprints may also be used to further augment this method.
266
Finally, the features derived using this method may be used to train supervised machine learning 267 models in order to further augment predictive performance.
268
In conclusion, we show that general patterns for molecular interactions may be identified through 269 frequent itemset mining, and that this method may be used to transfer insights mined from these 270 patterns to diverse application areas. 
